Apyx Medical (NASDAQ: APYX) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.06) by 46.43 percent. This is a 75 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $19.164 million which beat the analyst consensus estimate of $18.160 million by 5.53 percent. This is a 34.75 percent increase over sales of $14.222 million the same period last year.